Pediatrix Medical Group, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -12.8% | +20.4% | +15.2% | -43.3% | +19.6% | -41.0% | -62.5% | +117.5% | -17.7% | +50.4% | +31.2% | |
| – | +39.7% | +39.0% | +15.3% | +8.2% | -29.1% | -63.9% | +13.0% | +10.9% | +1.5% | -8.3% | -34.2% | |
| – | +1.3% | +5.8% | -13.0% | +30.9% | -8.7% | +10.4% | -51.4% | -15.0% | -23.6% | -3.7% | +52.0% | |
| – | +44.9% | +12.6% | -165.5% | – | +49,570.0% | -49.7% | -101.6% | – | – | – | – | |
| – | -339.7% | – | – | -182.5% | – | -45.8% | -144.3% | – | -136.5% | – | -52.6% | |
| – | +49.9% | +45.0% | +25.6% | -0.9% | -34.8% | -9.7% | +12.0% | -7.9% | +12.2% | -33.9% | -16.2% | |
| – | +68.4% | -3.2% | -29.8% | -75.2% | – | +696.0% | -106.5% | +7.3% | -15.4% | -26.5% | -48.3% | |
| – | +63.7% | -32.4% | +46.7% | -21.9% | -21.4% | -69.9% | – | – | – | – | – | |
| – | -51.9% | -73.7% | +13.5% | +330.5% | -51.9% | -94.2% | -44.4% | +1,775.6% | -99.0% | +85.3% | +4,990.0% | |
| – | +32.9% | -40.0% | -67.0% | -14.6% | -298.7% | -99.3% | +45,372.7% | -47.2% | -95.2% | -19.5% | +34.8% | |
| – | +394.0% | -21.0% | -76.5% | -290.1% | +130.4% | -98.9% | +18,180.8% | -35.9% | -94.7% | -43.7% | +642.1% | |
| – | -78.3% | +13.2% | +493.8% | -195.7% | – | +1,713.5% | -172.5% | – | – | +147.0% | -7.3% | |
| – | -15.6% | +18.4% | +14.2% | -47.8% | +30.6% | -44.1% | -74.7% | +208.5% | -24.2% | +77.5% | +36.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.